Gout is a very common form of inflammatory arthritis, affecting ~9.2 million adults (3.9%) in the U.S. Although the etiology of gout is well understood and effective, inexpensive medications exist to treat gout, gaps in quality of care persist. Below, explore selected content from The Rheumatologist’s collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of gout. New features are added often, so check back frequently.
With more than 40 research abstracts on gout accepted for presentation at ACR Convergence 2021, filtering the noise to get to the key thoughts may be challenging. Lisa Stamp, MBChB, PhD, can help. A rheumatologist, professor of medicine and the associate dean of research at the University of Otago in Christchurch, New Zealand, she has extensively researched the pathophysiology and management of gout. She brings us the highlights in “Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021.’“